Adult obesity and risk of severe infections: a multicohort study with global burden estimates
Adult obesity has been linked to specific infections, but evidence across the full spectrum of infectious diseases remains scarce.
Influenza hijacks myeloid cells to inflict type-I interferon-fueled damage in the heart
Abundant evidence has correlated influenza infection with cardiovascular disease, yet mechanisms linking infection with the heart remain poorly understood.
Influenza vaccination and the risk of myocardial infarction: a meta-epidemiology study
The association between influenza vaccination and the risk of myocardial infarction (MI) remains incompletely characterized, particularly in real-world populations.
Risk of Cardiorespiratory Events Following Respiratory Syncytial Virus–Related Hospitalization
In this self-controlled case series study of 11 887 patients, the risk of cardiorespiratory events after RSV-related hospitalization was significantly higher than during the control period.
Vaccination is vital to cardiovascular prevention, say heart specialists
The Society has published a Clinical Consensus Statement in the European Heart Journal highlighting the key role of vaccination in preventing cardiovascular events.
|
10th ESWI Influenza Conference 2025
When Infections Meet NCDs: The Bidirectional Relationship Between Cardiometabolic Conditions and Respiratory Viruses
Check out this Satellite Symposium organised by the ESWI IDC and supported by IFPMA and Sanofi from ESWI2026.
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
The pooled dataset encompassed 466,320 individually randomized participants, of whom 107,700 (23.1%) had a history of CVD.
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 European Society of Cardiology Conference
It highlights trials on novel therapies, vaccination, blood pressure management, and the use of technology and risk scores to guide treatment.
